New directions for the anti-retroviral chemotherapy of AIDS--a basis for a pharmacological approach to treatment.
Alderson
T
T
Department of Pharmacology, Cambridge University, UK.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000241:Adenosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000382:microbiology; D004279:DNA, Viral / Q000502:physiology; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008297:Male; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases / Q000502:physiology; D011499:Protein Processing, Post-Translational; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D012191:Retroviridae Proteins / Q000378:metabolism; D014158:Transcription, Genetic
D000998:Antiviral Agents; D004279:DNA, Viral; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012367:RNA, Viral; D012191:Retroviridae Proteins; D011065:Poly(ADP-ribose) Polymerases; D000241:Adenosine